People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Regen Biologics Inc | — | Biotechnology | Series A | $8.8M | $61.5M | 2009 |
J. Richard Steadman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside J. Richard Steadman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert G. McNeil | 1 | 5 |
| Jeffrey Chandler | 1 | 4 |
| Abhi Acharya | 1 | 3 |
| William R. Timken | 1 | 2 |
| Brion D. Umidi | 1 | 1 |
| James Flounlacker | 1 | 1 |
| John Dichiara | 1 | 1 |
| William G. Rodkey | 1 | 1 |
| Alan W. Baldwin | 1 | 1 |
| Gerald E. Bisbee, Jr. | 1 | 1 |
| William Rodkey | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.